UTUC
Showing 1 - 25 of 51
Neoadjuvant Immunotherapy Trial in Tianjin (tislelizumab+disitamab-vedotin)
Recruiting
- Neoadjuvant Immunotherapy
-
Tianjin, ChinaThe Second Hospital of Tianjin Medical University
Apr 20, 2023
Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal
Not yet recruiting
- Urothelial Carcinoma
- +7 more
- Jelmyto (mitomycin) for pyelocalyceal solution
- (no location specified)
May 22, 2023
Carcinoma, Upper Tract Urothelial Carcinoma, UTUC Trial in Nanjing (RC48-ADC and JS001)
Recruiting
- Carcinoma
- +2 more
- RC48-ADC and JS001
-
Nanjing, Jiangsu, ChinaJinling Hospital, Affiliated Hospital of Medical School, Nanjing
Jun 15, 2023
Physical and Biological Effects of Upper Tract Urothelial Cancer
Recruiting
- Upper Tract Urothelial Cancer
-
Hong Kong, Hong KongPrince of Wales Hospital
Jun 29, 2022
Upper Urinary Tract Carcinoma Trial
Not yet recruiting
- Upper Urinary Tract Carcinoma
- (no location specified)
Feb 7, 2023
Liquid Biospy for Urinary Cancers
Recruiting
- Urothelial Carcinoma
- Genetic analysis on isolated cells
-
Milan, ItalyUrology Department
Nov 6, 2023
Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy
Recruiting
- Urothelial Carcinoma
- Radiotherapy
- +2 more
-
Beijing, China
- +2 more
Nov 2, 2023
Upper Urinary Tract Urothelial Carcinoma, Kidney Preservation, HER-2 ADC Trial in Shanghai (RC48 Combined With Tislelizumab)
Recruiting
- Upper Urinary Tract Urothelial Carcinoma
- +3 more
- RC48 Combined With Tislelizumab
-
Shanghai, Shanghai, ChinaEthics Committee of Shanghai Renji Hospital
Jun 20, 2023
High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab
Not yet recruiting
- High Grade Urothelial Carcinoma
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Washington, District of Columbia
- +1 more
Jan 5, 2023
Genetic Testing in Upper Tract Urothelial Carcinoma: Epicheck
Recruiting
- Urologic Cancer
- Urologic Neoplasms
- Urine biomarker
-
Barcelona, SpainFundacio Puigvert
Jan 7, 2021
Immunotherapy in Upper Tract Urothelial Carcinoma
Not yet recruiting
- Urothelial Carcinoma
- Evaluation of anti-PD-(L)1 immunotherapy efficacy
- (no location specified)
Oct 27, 2023
Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial (ST-02)
Not yet recruiting
- Urothelial Carcinoma of the Renal Pelvis and Ureter
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- (no location specified)
Nov 7, 2023
Upper Urinary Tract Urothelial Carcinoma, Bladder Cancer Trial in Vienna (Intravesical Solution)
Not yet recruiting
- Upper Urinary Tract Urothelial Carcinoma
- Bladder Cancer
- Intravesical Solution
-
Vienna, Austria
- +1 more
Mar 31, 2023
Circulating Tumour DNA and Urine Tumor DNA Detection of Minimal
Recruiting
- Muscle Invasive Upper Tract Urothelial Carcinoma
- Adjuvant chemotherapy
- adjuvant immunotherapy
-
Shanghai, Shanghai, ChinaRenji Hospital
Oct 30, 2022
Transitional Cell Cancer of Renal Pelvis and Ureter Trial in New York, Myrtle Beach, Paris (padeliporfin VTP)
Recruiting
- Transitional Cell Cancer of Renal Pelvis and Ureter
- padeliporfin VTP
-
Albany, New York
- +6 more
Jan 3, 2023
An Observational Study of Upper Tract Urothelial Cancer
Not yet recruiting
- Upper Tract Urinary Carcinoma
- (no location specified)
Apr 22, 2022
Upper Urinary Tract Urothelial Carcinoma Trial in Kaohsiung (Nivolumab 100 MG in 10 ML Injection)
Recruiting
- Upper Urinary Tract Urothelial Carcinoma
- Nivolumab 100 MG in 10 ML Injection
-
Kaohsiung, TaiwanKaohsiung Chang Gung Memorial Hospital
Dec 2, 2021
Upper Tract Urothelial Carcinoma Trial in Netherlands, Norway, Spain (RNU, Gemcitabine/Cisplatin, M-VAC Protocol)
Recruiting
- Upper Tract Urothelial Carcinoma
- RNU
- +2 more
-
Nijmegen, Gelderland, Netherlands
- +26 more
Apr 6, 2022
Carcinoma, Transitional Cell, Transitional Cell Carcinoma of Renal Pelvis Trial in Israel, United States (UGN-101 instillations)
Completed
- Carcinoma, Transitional Cell
- Transitional Cell Carcinoma of Renal Pelvis
- UGN-101 instillations
-
Phoenix, Arizona
- +23 more
Dec 1, 2020
Urothelial Carcinoma, Cancer Trial in France (Patients receiving neoadjuvant therapy before radical nephrectomy)
Recruiting
- Urothelial Carcinoma
- Cancer
- Patients receiving neoadjuvant therapy before radical nephrectomy
-
Paris, Paris Cx 20, France
- +7 more
Dec 23, 2021
Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial
Available
- Urothelial Cancer of Renal Pelvis
- +5 more
- Mitomycin for pyelocalyceal solution
- (no location specified)
Aug 5, 2022
Upper Tract Urinary Carcinoma, Muscle-invasive Bladder Cancer Trial in Beijing (Toripalimab)
Recruiting
- Upper Tract Urinary Carcinoma
- Muscle-invasive Bladder Cancer
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Mar 12, 2022
High-Grade Upper Tract Urothelial Carcinoma Trial in Changsha (Radical nephroureterectomy, Distal ureterectomy, Neoadjuvant
Unknown status
- High-Grade Upper Tract Urothelial Carcinoma
- Radical nephroureterectomy
- +2 more
-
Changsha, Hunan, ChinaXiangya Hospital of Central South Univeristy
Jul 3, 2019
Renal Pelvis and Ureter Urothelial Carcinoma Trial in Houston (drug, other, procedure)
Active, not recruiting
- Renal Pelvis and Ureter Urothelial Carcinoma
- Infigratinib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 21, 2022